Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹97 Cr
Revenue (TTM)
₹79 Cr
Net Profit (TTM)
₹9 Cr
ROE
32.5 %
ROCE
15 %
P/E Ratio
11.3
P/B Ratio
3.1
Industry P/E
37.29
EV/EBITDA
11.8
Div. Yield
0 %
Debt to Equity
1.3
Book Value
₹23.6
EPS
₹6.5
Face value
10
Shares outstanding
13,149,312
CFO
₹6.54 Cr
EBITDA
₹29.75 Cr
Net Profit
₹12.89 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Raaj Medisafe
| 4.9 | -14.2 | 8.0 | 0.5 | 41.9 | 45.0 | -- |
|
BSE Healthcare*
| -3.0 | -2.7 | -3.0 | 4.1 | 25.1 | 15.7 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Raaj Medisafe
| -13.6 | 113.9 | 17.6 | -21.3 | 296.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Raaj Medisafe
|
73.5 | 96.6 | 79.3 | 8.6 | 13.0 | 30.6 | 11.3 | 3.1 |
| 242.7 | 138.7 | 34.5 | -3.4 | -5.4 | -48.6 | -- | 10.1 | |
| 1,625.4 | 27,406.4 | 6,112.8 | 847.2 | 17.2 | 9.2 | 32.4 | 2.8 | |
| 138.4 | 76.3 | 35.4 | 5.8 | 15.4 | 17 | 13.2 | 1.9 | |
| 840.1 | 10,147.0 | 6,537.7 | 207.0 | 4.6 | 11.5 | 49 | 5.3 | |
| 245.0 | 237.7 | 143.3 | 10.6 | 3.5 | 5.4 | 22.3 | 1.3 | |
| 1,256.8 | 12,965.9 | 1,781.6 | 341.3 | 19.8 | 12.4 | 37.3 | 4.3 | |
| 76.4 | 147.7 | 173.0 | 13.5 | 12.9 | 12.1 | 12.5 | -- | |
| 187.7 | 994.2 | 414.3 | 20.3 | 8.0 | 3.4 | 48.9 | 1.6 |
No Review & Analysis are available.
Manufacture of medical and dental instruments and supplies
Incorporated
1985
Chairman
Arpit Bangur
Managing Director
Arpit Bangur
Headquarters
Ujjain, Madhya Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsUnaudited Financial Results -December 31 2025
11-Feb-2026Proceedings Of EGM Dated 20.01.2026
21-Jan-2026
The share price of Raaj Medisafe India Ltd is ₹73.47 (BSE) as of 18-Mar-2026 IST. Raaj Medisafe India Ltd has given a return of 41.89% in the last 3 years.
The P/E ratio of Raaj Medisafe India Ltd is 11.28 times as on 18-Mar-2026, a 70 discount to its peers’ median range of 37.29 times.
The P/B ratio of Raaj Medisafe India Ltd is 3.12 times as on 18-Mar-2026, a 28 discount to its peers’ median range of 4.34 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.80
|
3.60
|
|
2024
|
17.71
|
5.44
|
|
2023
|
7.65
|
3.40
|
|
2022
|
14.15
|
10.27
|
|
2021
|
6.55
|
14.04
|
The 52-week high and low of Raaj Medisafe India Ltd are Rs 102.35 and Rs 64.08 as of 19-Mar-2026.
Raaj Medisafe India Ltd has a market capitalisation of ₹ 97 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Raaj Medisafe India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹3.49
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.